{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:29:02Z","timestamp":1784204942825,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s00432-022-03974-7","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T05:27:34Z","timestamp":1651210054000},"page":"1931-1942","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Individualized clinical target volume delineation and efficacy analysis in unilateral nasopharyngeal carcinoma treated with intensity-modulated radiotherapy (IMRT): 10-year summary"],"prefix":"10.1007","volume":"148","author":[{"given":"De-Huan","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang-Zhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Qin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Lan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Wen","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei-Fei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nian-Ji","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Min","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai-Xiang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Qian","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8888-8694","authenticated-orcid":false,"given":"Yong","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,29]]},"reference":[{"key":"3974_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.oraloncology.2017.12.004","volume":"77","author":"KH Au","year":"2018","unstructured":"Au KH, Ngan Roger KC, Ng Alice WY et al (2018) Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study). Oral Oncol 77:16\u201321","journal-title":"Oral Oncol"},{"key":"3974_CR2","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1093\/jnci\/djr432","volume":"103","author":"Q-Y Chen","year":"2011","unstructured":"Chen Q-Y, Wen Y-F, Guo L et al (2011) Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial. J Natl Cancer Inst 103:1761\u20131770","journal-title":"J Natl Cancer Inst"},{"key":"3974_CR3","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1634\/theoncologist.2017-0577","volume":"24","author":"L Chen","year":"2019","unstructured":"Chen L, Zhang Y, Lai S-Z et al (2019) 10-year results of therapeutic ratio by intensity-modulated radiotherapy versus two-dimensional radiotherapy in patients with nasopharyngeal carcinoma. Oncologist 24:e38\u2013e45","journal-title":"Oncologist"},{"key":"3974_CR4","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/S0360-3016(02)03940-8","volume":"55","author":"CKS Clifford","year":"2003","unstructured":"Clifford CKS, Ozyigit G, Tran BN et al (2003) Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 55:312\u2013321","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3974_CR5","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/S0360-3016(99)00550-7","volume":"46","author":"LA Dawson","year":"2000","unstructured":"Dawson LA, Anzai Y, Marsh L et al (2000) Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 46:1117\u20131126","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3974_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.radonc.2017.10.016","volume":"126","author":"V Gr\u00e9goire","year":"2018","unstructured":"Gr\u00e9goire V, Evans M, Le Q-T et al (2018) Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO TROG Consensus Guidelines. Radiother Oncol 126:3\u201324","journal-title":"Radiother Oncol"},{"key":"3974_CR7","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.ijrobp.2010.03.024","volume":"80","author":"S-Z Lai","year":"2011","unstructured":"Lai S-Z, Li W-F, Chen L et al (2011) How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients? Int J Radiat Oncol Biol Phys 80:661\u2013668","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3974_CR8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S0360-3016(02)02724-4","volume":"53","author":"N Lee","year":"2002","unstructured":"Lee N, Xia P, Quivey Jeanne M et al (2002) Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 53:12\u201322","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3974_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.radonc.2017.10.032","volume":"126","author":"W Lee Anne","year":"2018","unstructured":"Lee Anne W, Ng WT, Pan JJ et al (2018) International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma. Radiother Oncol 126:25\u201336","journal-title":"Radiother Oncol"},{"key":"3974_CR10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ejca.2018.10.020","volume":"110","author":"X-Y Li","year":"2019","unstructured":"Li X-Y, Chen Q-Y, Sun X-S et al (2019) Ten-year outcomes of survival and toxicity for a phase III randomised trial of concurrent chemoradiotherapy versus radiotherapy alone in stage II nasopharyngeal carcinoma. Eur J Cancer 110:24\u201331","journal-title":"Eur J Cancer"},{"key":"3974_CR11","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S1470-2045(20)30673-2","volume":"22","author":"Y-P Liu","year":"2021","unstructured":"Liu Y-P, Wen Y-H, Tang J et al (2021) Endoscopic surgery compared with intensity-modulated radiotherapy in resectable locally recurrent nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet Oncol 22:381\u2013390","journal-title":"Lancet Oncol"},{"key":"3974_CR12","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.ijrobp.2018.05.060","volume":"102","author":"J McDowell Lachlan","year":"2018","unstructured":"McDowell Lachlan J, Rock K, Xu W et al (2018) Long-Term late toxicity, quality of life, and emotional distress in patients with nasopharyngeal carcinoma treated with intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys 102:340\u2013352","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3974_CR13","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.ijrobp.2020.03.029","volume":"107","author":"J Miao","year":"2020","unstructured":"Miao J, Di M, Chen B et al (2020) A prospective 10-year observational study of reduction of radiation therapy clinical target volume and dose in early-stage nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 107:672\u2013682","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3974_CR14","unstructured":"National Comprehensive Cancer Network (2018) (NCCN) Clinical Practice Guidelines in Oncology. Head and Neck Cancer, Version 1. 2018. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/head-and-neck.pdf. Accessed 15 Feb 2018"},{"key":"3974_CR15","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ijrobp.2021.01.041","volume":"110","author":"WT Ng","year":"2021","unstructured":"Ng WT, Soong YL, Ahn YC et al (2021) International recommendations on reirradiation by intensity modulated radiation therapy for locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 110:682\u2013695","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3974_CR16","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.ijrobp.2018.10.006","volume":"103","author":"N Sanford Nina","year":"2019","unstructured":"Sanford Nina N, Jackson L, Lam Miranda B et al (2019) Individualization of clinical target volume delineation based on stepwise spread of nasopharyngeal carcinoma: outcome of more than a decade of clinical experience. Int J Radiat Oncol Biol Phys 103:654\u2013668","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3974_CR17","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.ijrobp.2010.09.011","volume":"82","author":"S-F Su","year":"2012","unstructured":"Su S-F, Han F, Zhao C et al (2012) Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone. Int J Radiat Oncol Biol Phys 82:327\u2013333","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3974_CR18","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.radonc.2013.10.035","volume":"110","author":"Y Sun","year":"2014","unstructured":"Sun Y, Yu X-L, Luo W et al (2014) Recommendation for a contouring method and atlas of organs at risk in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy. Radiother Oncol 110:390\u2013397","journal-title":"Radiother Oncol"},{"issue":"S1","key":"3974_CR19","doi-asserted-by":"publisher","first-page":"E468","DOI":"10.1002\/hed.24020","volume":"38","author":"Y Sun","year":"2016","unstructured":"Sun Y, Yu X-L, Zhang G et al (2016) Reduction of clinical target volume in patients with lateralized cancer of the nasopharynx and without contralateral lymph node metastasis receiving intensity-modulated radiotherapy. Head Neck 38(S1):E468\u2013E472","journal-title":"Head Neck"},{"key":"3974_CR20","doi-asserted-by":"publisher","first-page":"685","DOI":"10.4143\/crt.2018.250","volume":"51","author":"L Wang","year":"2019","unstructured":"Wang L, Wu Z, Xie D et al (2019) Reduction of target volume and the corresponding dose for the tumor regression field after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma. Cancer Res Treat 51:685\u2013695","journal-title":"Cancer Res Treat"},{"key":"3974_CR21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.oraloncology.2017.03.015","volume":"69","author":"L-R Wu","year":"2017","unstructured":"Wu L-R, Liu Y-T, Jiang N et al (2017) Ten-year survival outcomes for patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: an analysis of 614 patients from a single center. Oral Oncol 69:26\u201332","journal-title":"Oral Oncol"},{"key":"3974_CR22","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/ajco.13475","volume":"17","author":"Z Wu","year":"2021","unstructured":"Wu Z, Wang L, Xie D-H et al (2021) Failure patterns and prognostic factors for cervical node-negative nasopharyngeal carcinoma in the intensity-modulated radiotherapy era. Asia Pac J Clin Oncol 17:330\u2013337","journal-title":"Asia Pac J Clin Oncol"},{"key":"3974_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40880-019-0364-x","volume":"39","author":"D Xie","year":"2019","unstructured":"Xie D, Cheng W, Lv S et al (2019) Target delineation and dose prescription of adaptive replanning intensity-modulated radiotherapy for nasopharyngeal carcinoma. Cancer Commun (lond) 39:18","journal-title":"Cancer Commun (lond)"},{"key":"3974_CR24","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1148\/radiol.14141721","volume":"276","author":"L Zeng","year":"2015","unstructured":"Zeng L, Huang S-M, Tian Y-M et al (2015) Normal tissue complication probability model for radiation-induced temporal lobe injury after intensity-modulated radiation therapy for nasopharyngeal carcinoma. Radiology 276:243\u2013249","journal-title":"Radiology"},{"key":"3974_CR25","doi-asserted-by":"publisher","first-page":"17378","DOI":"10.1038\/srep17378","volume":"5","author":"F Zhang","year":"2015","unstructured":"Zhang F, Zhang Y, Li W-F et al (2015) Efficacy of concurren chemotherapy for intermediate risk NPC in the intensity-modulated radiotherapy era: a propensity-matched analysis. Sci Rep 5:17378","journal-title":"Sci Rep"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-022-03974-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-022-03974-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-022-03974-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T04:06:41Z","timestamp":1658117201000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-022-03974-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,29]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["3974"],"URL":"https:\/\/doi.org\/10.1007\/s00432-022-03974-7","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,29]]},"assertion":[{"value":"23 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/Competing interests"}},{"value":"Retrospective ethical approval was obtained from the institutional ethics committee of the Sun Yat\u2011sen University Cancer Center, with the approval number B2019-169\u201301. Written informed treatment consents were required from all patients with respect to chemotherapy and\/or radiotherapy.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}